Mutations in K-Ras4B, a splice variant of K-Ras, occur in up to 90% of pancreatic cancers [2,3], 57% of colorectal cancers [4] and 50% of lung cancers [1,5,6]. This evidence concerns the gene KRAS and lung cancer.